RhoA/ROCK-dependent signaling pathways are critically involved in pathological conditions, including pulmonary hypertension [64], heart attack [65], stroke [66], Alzheimer’s disease [67], glaucoma [68], diabetes and hypertensive nephropathy [69,70]. Here, RHOA is linked to early-onset autosomal dominant Alzheimer disease.